A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa - Wikidata - awgldk - TriplyDB

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

http://www.wikidata.org/entity/Q34687538

about

Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy Getting to 90-90-90 in paediatric HIV: What is needed?Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study.Antimicrobial resistance of Klebsiella pneumoniae stool isolates circulating in Kenya Poor clinical outcomes for HIV infected children on antiretroviral therapy in rural Mozambique: need for program quality improvement and community engagement Co-detection of Panton-Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus aureus in Gabon: implications for HIV-patients' care.Opportunities for improving the efficiency of paediatric HIV treatment programmes.The effect of daily co-trimoxazole prophylaxis on natural development of antibody-mediated immunity against P. falciparum malaria infection in HIV-exposed uninfected Malawian children The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events.Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.Non-Nucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy in Perinatally HIV-Infected, Treatment-Naïve Adolescents in Asia.The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'.Early Height and Weight Changes in Children Using Cotrimoxazole Prophylaxis With Antiretroviral Therapy Brief Report: Prevalence of Latent Rheumatic Heart Disease Among HIV-Infected Children in Kampala, Uganda.Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study.Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults.Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial.Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis.Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial.Survival of HIV-1 vertically infected children.Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines.Effect of cotrimoxazole prophylaxis on malaria occurrence among HIV-infected adults in West Africa: the MALHIV Study.Failure of Syndrome-Based Diarrhea Management Guidelines to Detect Shigella Infections in Kenyan Children.Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life.Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for Skin and Soft Tissue Infections Including Impetigo, Cellulitis, and Abscess.Azithromycin to prevent post-discharge morbidity and mortality in Kenyan children: a protocol for a randomised, double-blind, placebo-controlled trial (the Toto Bora trial).HIV Infection and risk of postpartum infection, complications and mortality in rural Uganda.Developments in pediatric infectious diseases: a review of WSPID 2013.Sulfamethoxazole Levels in HIV-Exposed Uninfected Ugandan Children.Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trial.Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.

P2860

Q26774267-1D9C6A59-5BA6-4464-9397-2104E4EBADE4 Q27009235-30D47B2E-F5E5-4FDC-A279-75BA5A22DF1B Q28084902-F3C87ADE-84F5-4FD2-9776-B301CFAC958B Q28552031-D2A3AF0F-818C-476B-BE17-05E151B052B4 Q28602123-9E699DAF-E493-4064-B751-08D69DE4FA4A Q30385352-05288B4F-1D4B-47DD-8948-76EFBA5FAA03 Q33622785-3D87838F-E62B-4E7A-BF83-E1B0ED83840B Q33757902-2AAF98DE-E49C-49AB-A558-61EBFA28D5EE Q34374033-6160D831-C4F6-48E1-A3CB-3E8BCE1F0B7D Q35053423-1A122A0C-9E4E-4AE8-BA1D-E05378DFEA29 Q35054163-A8AE01CA-1D46-4003-93FA-8DEC3B7ED63B Q35217416-ECD33351-D5A4-46B6-8A3B-6B79FBA5F08A Q35513977-6464E420-2F0E-4D93-9DFD-1381652FDE2F Q35626884-8162CC02-4F6E-4205-BBB0-4B109C5685EC Q35804683-EE4F5D5D-4BD2-43EF-BF06-B1585CF87645 Q35902391-F8FDBE84-BEE5-4048-8F19-57FE3D7DCD3A Q35929458-10F4573D-D9CD-4BA4-B685-A0C32C193435 Q36089141-F7E83FCA-5CF6-4295-893A-10C4A370274D Q36460065-8B791A73-4BB4-4223-89B4-3DD77CDE47A9 Q36517673-6D19B28A-1A56-443C-B395-EC5C5FB32804 Q37097177-1B1AE1F2-5DD2-4130-9CD8-90B2BA9BFF4F Q37391118-CB1A875A-0759-490A-8DFD-1B6D55479E1C Q37613241-48908B03-145C-4D21-875D-B24932948668 Q37742040-9BDD5D5A-515E-4564-AA19-F5D7C102D89E Q38843857-F4206CB3-C479-45E0-BDBE-95CB831F8D4D Q38852917-E7C7430B-9423-472E-BD59-D5441F7DA6F1 Q38905487-01230E97-AC11-483E-9512-301741808FD3 Q38975088-BF9BEF95-9652-4B89-9E78-85D66FA7C794 Q40056576-0263876F-D7AC-4AB3-8433-E274333ECF6B Q40097078-0CBD428E-CC7C-4658-9D46-90B3AB779DA2 Q40144262-78F89D67-E86D-48FC-8117-54E44FD8E1AF Q40981696-A7D1A56D-7F4D-477A-BC1A-D1EA5047AEBC Q41505058-6EAA00F2-2B1E-4321-BAE1-C3CAA7B548B9 Q47104755-B38B53F5-5D07-474C-97C6-D61070CFABFC Q47182935-290E4597-B844-4B1D-BC62-918EC417937D Q49943871-1F348FE0-FAC1-424A-9660-09E90180CDAD Q50478243-D786C100-BF0A-43CA-9B28-0607C7294A4A Q52564899-E1A40802-42C6-4D66-941C-259C9690FE54 Q53691502-A0DEA6D0-7E9A-4546-BB74-432B108D70DF Q54260534-9071B0EE-73C5-4345-BF9D-04FA0860C01B

P2860

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

http://www.wikidata.org/entity/Q34687538

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@ast

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@en

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@nl

type

label

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@ast

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@en

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@nl

prefLabel

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@ast

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@en

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@nl

P1433

Q34687538-610E38AC-8CCC-4572-8CA8-0B88B287A1E9

P1476

Q34687538-3AE9C07C-05F9-4585-85FE-B725F44E7371

P2093

Q34687538-0CFA3F88-872F-4097-A0ED-C1E7A0F7C162

Q34687538-2533CCF3-CA5C-4CF4-A7DB-DEE5D7AA8826

Q34687538-30915E7B-E73C-4CDF-AEE4-62EB2CE10DA1

Q34687538-3C6CC6AB-A25E-4D84-9FBE-DD94A0F339C0

Q34687538-3EAAAFFF-4E68-4FE9-A44C-9A6269D523C2

Q34687538-508BB0BE-3AD3-4F3A-ADC1-F4BB94C86A54

Q34687538-59ABA27D-2021-4121-89F1-C9DCCD750F48

Q34687538-624FD9A7-E871-42EA-886C-F3C9A4B7F062

Q34687538-7CA0AFB5-F00C-4E85-91BE-BB92171DDCC3

Q34687538-8EF182DD-BCB6-4059-BF97-4D8EECD91500

P2860

Q34687538-27F59DC2-FFBC-48BB-A12E-0E8A708309DF

Q34687538-37000718-7E39-4B6D-A9B8-EB4078884622

Q34687538-3E3D3DF0-5CD0-4090-87C8-C01FA4C8AEC9

Q34687538-3E7F4043-E08E-4D80-BDC7-CF1FA6DCAB3E

Q34687538-46012F3C-2E1B-4535-8C47-C31487130A7F

Q34687538-4A316A78-0CDE-49B7-A595-41F03A094E83

Q34687538-5017DA3B-6455-450F-B048-22EEAE7BEC06

Q34687538-56F38DB1-1757-4358-A329-5082DF01B047

Q34687538-6243C10F-83F5-4D86-A1AB-B837A8C61545

Q34687538-639B2968-05DC-4F90-8023-9091227A0FB4

P304

Q34687538-9BE168B1-00BA-4B3D-8E5C-817599A6CF5E

P31

Q34687538-16C84835-F0B0-4452-A9AF-ECD8E24DCDBE

P356

Q34687538-2A0FDF08-76AF-465A-993C-1DE23BD187E5

P407

Q34687538-9FCBA52B-B64C-4344-A08B-C4A9591F82CB

P433

Q34687538-CB93F3EE-B9AC-4B98-8300-EA75BFC34302

P478

Q34687538-5210A4B4-2078-4F14-A099-BF8C60F09E7A

P50

Q34687538-B55DB7DA-366B-4AE9-9480-819187B52037

Q34687538-BB8819E8-F8B8-4640-95C1-4B59F0E6B9AA

Q34687538-D2A45A4B-5F3A-44E5-9C15-CC987B360F48

Q34687538-D9E288BF-B1DC-487D-A408-FD1A1B9FA8B6

P577

Q34687538-231292CA-0F61-46EB-9ED1-B8CA90357705

P698

Q34687538-ED1D2333-0BEE-4DFC-9BD2-174BEE772F25

P932

Q34687538-6AF9ED81-4BF5-472E-9538-CC0259A6EDC4

P356

P1433

The New England Journal of Medicine

P1476

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

@en

P2093

A Sarah Walker

http://www.w3.org/2001/XMLSchema#string

Adeodata Kekitiinwa

http://www.w3.org/2001/XMLSchema#string

Diana M Gibb

http://www.w3.org/2001/XMLSchema#string

Joseph Lutaakome

http://www.w3.org/2001/XMLSchema#string

Kusum Nathoo

http://www.w3.org/2001/XMLSchema#string

Lindsay Kendall

http://www.w3.org/2001/XMLSchema#string

Moira J Spyer

http://www.w3.org/2001/XMLSchema#string

Patricia Nahirya-Ntege

http://www.w3.org/2001/XMLSchema#string

Paula Munderi

http://www.w3.org/2001/XMLSchema#string

Rosette Keishanyu

http://www.w3.org/2001/XMLSchema#string

P2860

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

Tuberculosis and trimethoprim-sulfamethoxazole

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects.

Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.

Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study.

Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda.

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial.

AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire

P304

41-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1214901

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P50

Phillip Kasirye

Mutsa Bwakura-Dangarembizi

Andrew Prendergast

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24382064

http://www.w3.org/2001/XMLSchema#string

P932

4264559

http://www.w3.org/2001/XMLSchema#string